Developing a Nationwide Infrastructure for Therapeutic Drug Monitoring of Targeted Oral Anticancer Drugs: The ON-TARGET Study Protocol
Simple Summary
Mc Laughlin, A.M.; Schmulenson, E.; Teplytska, O.; Zimmermann, S.; Opitz, P.; Groenland, S.L.; Huitema, A.D.R.; Steeghs, N.; Müller, L.; Fuxius, S.; Illerhaus, G.; Joerger, M.; Mayer, F.; Fuhr, U.; Holdenrieder, S.; Hempel, G.; Scherf-Clavel, O.; Jaehde, U.; Kloft, C.; for the ON-TARGET Study Consortium. Developing a Nationwide Infrastructure for Therapeutic Drug Monitoring of Targeted Oral Anticancer Drugs: The ON-TARGET Study Protocol. Cancers 2021, 13, 6281. https://doi.org/10.3390/cancers13246281
Mc Laughlin AM, Schmulenson E, Teplytska O, Zimmermann S, Opitz P, Groenland SL, Huitema ADR, Steeghs N, Müller L, Fuxius S, Illerhaus G, Joerger M, Mayer F, Fuhr U, Holdenrieder S, Hempel G, Scherf-Clavel O, Jaehde U, Kloft C, for the ON-TARGET Study Consortium. Developing a Nationwide Infrastructure for Therapeutic Drug Monitoring of Targeted Oral Anticancer Drugs: The ON-TARGET Study Protocol. Cancers. 2021; 13(24):6281. https://doi.org/10.3390/cancers13246281
Chicago/Turabian StyleMc Laughlin, Anna M., Eduard Schmulenson, Olga Teplytska, Sebastian Zimmermann, Patrick Opitz, Stefanie L. Groenland, Alwin D.R. Huitema, Neeltje Steeghs, Lothar Müller, Stefan Fuxius, Gerald Illerhaus, Markus Joerger, Frank Mayer, Uwe Fuhr, Stefan Holdenrieder, Georg Hempel, Oliver Scherf-Clavel, Ulrich Jaehde, Charlotte Kloft, and for the ON-TARGET Study Consortium. 2021. "Developing a Nationwide Infrastructure for Therapeutic Drug Monitoring of Targeted Oral Anticancer Drugs: The ON-TARGET Study Protocol" Cancers 13, no. 24: 6281. https://doi.org/10.3390/cancers13246281